Exercise matched antidepressants for non-severe depression

Antidepressants are the default medical response to depression, but for adults whose depression is not severe, the question of whether structured exercise could do the same job is a live one. If movement genuinely rivals medication, it becomes a legitimate option for people who cannot tolerate drugs, do not want them, or want something to add alongside them. Individual trials have compared these approaches in pairs, but a network meta-analysis can rank all three, exercise, antidepressants and their combination, against each other and against control conditions in a single analysis. That is what this review set out to do.

The researchers searched seven databases for randomised controlled trials published from 1990 onwards that tested an exercise, antidepressant or combined intervention against either treatment alone or a control or placebo condition in adults with non-severe depression. Twenty-one trials with 2551 participants and 25 comparisons made it into the network. Two independent investigators assessed risk of bias, indirectness and overall confidence in the network. The main outcome was the difference in depressive symptom severity after the intervention, and drop-out from each intervention was tracked as a measure of how acceptable people found the treatment.

There were no differences in effectiveness among the three main interventions: exercise against antidepressants, combination against exercise, and combination against antidepressants all produced statistically indistinguishable results. All three treatments were more beneficial than control conditions, so the equivalence is not a case of nothing working. The notable divergence came in adherence rather than effect: exercise interventions had higher drop-out rates than antidepressant interventions, with a risk ratio of 1.31. Heterogeneity across the network was moderate, meaning the trials agreed with each other reasonably well but not perfectly.

This analysis strengthens the case that exercise is not merely a feel-good add-on for milder depression but a treatment that holds its own against medication in head-to-head evidence. It also complicates the simple story in a useful way: combining exercise with antidepressants added nothing measurable over either alone, and exercise's weakness is that people abandon it more readily. The findings apply strictly to non-severe depression, so nothing here speaks to severe illness. Open questions remain about which types, doses and formats of exercise work best, which this network could not settle.

For adults dealing with milder depression, this is evidence that movement belongs in the same conversation as medication, not beneath it: across 21 trials, the two approaches relieved symptoms about equally, and both clearly beat doing nothing. It is also a candid warning about the real-world weakness of exercise as treatment, which is that people stop doing it more often than they stop taking tablets. The honest reading is that the best treatment among equals is the one a person will actually continue. Treatment decisions for depression are conversations to have with a clinician, not a feed.